Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12FN5O3 |
| Molecular Weight | 269.2324 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2[C@H]3C[C@H](F)[C@@H](CO)O3)C(=O)N1
InChI
InChIKey=RTJUXLYUUDBAJN-KVQBGUIXSA-N
InChI=1S/C10H12FN5O3/c11-4-1-6(19-5(4)2-17)16-3-13-7-8(16)14-10(12)15-9(7)18/h3-6,17H,1-2H2,(H3,12,14,15,18)/t4-,5+,6+/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo. | 1996 Mar |
|
| In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. | 2005 Mar |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C97452
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9105
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
UU109JJU0U
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
C90784
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
135431817
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
300000036985
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
92562-88-4
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY | |||
|
DTXSID90239044
Created by
admin on Sat Dec 16 17:37:55 GMT 2023 , Edited by admin on Sat Dec 16 17:37:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
